線維素溶解現象の研究
スポンサーリンク
概要
- 論文の詳細を見る
Fibrinolytic phenomenon is attributed to an increase of plasmin which is activated by the system of proactivator and activator. The fibrin plate method, which is widely used at present for the purpose of measuring plasmin, has some disadvantages when quantitative measurement of a very small amount of plasmin is required. In this report, the fibrin tube method which was newly devised for the purpose of titrating a very small amount of plasmin is described. Moreover, plasma plasmin in normal healthy persons and that of patients with various diseases was measured by this new method and a relation between diseases and their plasmin value is discussed. Thus, in order to appreciate the property of serum and tissue activators, we tried to separate and extract activators from human serum and tissues. After the measurement method of the tissue activators was examined, the value of activator was determined concerning cancer tissues and mucosae of gastric ulcer obtained from the surgical specimens, and gastric mucosae and various organs from sudden death cadavers. Finally, the corresponding relationship between the activator value and the plasmin value is discussed. I. Fibrin-Tube Method. (1) The fibrin obtained from various animals was examined first. The coagulating conditions of the fibrin incubated for 18 hrs. at 37℃. was investigated, and it was found that bovine fibrin was most available in the bovine, canine, pig's and rabbit's fibrin. (2) Astrup's fibrin plate method was then examined. Conditions of fibrinolysis of the plate colored with carmin suspension were investigated, and four types of fibrinolysis could be differentiated in consequence. 1) Type I : Saucer form- the lysis which does not reach to the base of the petri dish. 2) Type II : Crater form- the lysis reaches to the base of the petri dish, but the area of lysis is narrower at the base than at the surface. 3) Type III : Complete form- the lysis reaches to the base of the petri dish, and the area of the base is equal to that of the surface. 4) Type IV : Triangle flask form- the lysis reaches to the base of the petri dish, but the area of lysis is larger at the base than at the surface. These four types of lysis could not be differentiate by the non-colored plat method of Astrup's. At the time of practical measurement of the lysed area, the value varied in how to decide the lysed diameter. In the case of type I, particularly, the quantitative measurement of plasmin became impossible. (3) For the purpose of quantitative measurement of plasmin, especially that of low activity such as in healthy normal persons, the fibrin tube method was devised in this report. A mass of fibrin colored with carmin was prepared in glass tubes which had a constant inner diameter, and the material to be measured was piled on the mass. The lysed distance was then measured after incubation. As a result of this examination under various conditions, the following was adopted in this report : a clottable protein concentration of 400mg/dl ; the volume of material used was 1.0 ml ; and measurement of the lysed distance was done after incubation for 18 hrs. at 37℃. The fibrin tube method could be compared with the fibrin plate method by means of multiplying the certain conistants. (4) Lastly, the heated fibrin tube method was attempted. The water bath for 10 minutes at 55℃. was most convenient, because of less degeneration of the fibrin, and satisfactory inactivation of the plasmin in the fibrin mass. II. Comparison of the Plasma Plasmin Value Between Healthy Normal Persons, and Patients with Various Diseases Using the Fibrin Tube Method. (1) The plasmin value was determined by the fibrin tube method devised for the quantitative measurement of a small amount of plasmin. The materials were prepared as follows : Plasma was separated from human blood which was prevented from coagulating by an addition of 1/10 volume of 10% w/v sodium citrate. Precipitate of the plasma at pH 5.2 was redissolved in the original volume of the pH 7.8 HCl-Sodium diethylbarbiturate buffer solution. (2) The plasmin value of a normal person was estimated every tow hours, and it was suggested that the value of plasmin was alterative periodically in a day. Practically, the value was minimum at the time of arising and maximum between 3-5 p.m. Measurement of the plasmin value in 13 normal healthy males and 13 females at early morning provided an average of 1.05mm for the male, and 0.96mm for the female. Maximum value was 1.90mm for both sexes. (3) Estimation of the plasmin value in patients with various diseases at early morning was carried out, on the assumption that the maximum limit in the normal persons was 2.0 mm. One hundred and tow patients, all preoperative, were studied at Chiba university hospital. The diseases involved were gastric cancer, esophagocardiac cancer, gastroduodenal ulcer, and others. The average in plasmin values of nearly all the patients was 1.75mm, with σ at 0.89mm. In the cases of gastric cancer, gastroduodenal ulcer, and esophagocardiac cancer, which there were many, the plasmin value indicated higher than when in a normal healthy state. Liver function of the patients was examined due to an increasing of plasmin being attributed to liver diseases by some authors, but a relation between the plasmin value and the liver function could not be correlated. III. Estimation of the Tissue Activators. Measurement of the tissue activator was carried out as follows : the tissues added to 2 M KSCN were homogenated completely and extracted by shaking for 2hrs. The centrifuged supernatant of the extract was then dialysed thoroughly against pH 7.0, 0.1M phosphate buffer solution over night at 4℃., and the dialysed precipitate was collected by centrifugation. The precipitate was added to the plasminogen solution prepared from human serum and Incubated for 5hrs. at 37℃. Then the mixture was centrifuged and the supernatant was titrated by the fibrin plate method. (1) The tissue activators of various organs from cadavers were estimated with the result indicating no direct relationship between the tissue activator value and the course of death. (2) Intensity of the tissue activators ranged almost as follows : the kidney, the suprarenal gland, the liver, the gastric mucosa, the brain, etc. (3) Tissue activator values in patients with gastric cancer and gastric ulcer were higher than those of the gastric mueosa of the cadavers. (4) A direct relationship could not be found between the pre-operative plasma plasmin value of the patients and the tissue activator value of their surgical specimens. However, the group indicated the high value plasma plasmin had as well as the high tissue activator on an average.
- 千葉大学の論文
- 1965-05-28
著者
関連論文
- 1125 バイオ人工肝補助システムに適したヒト肝由来細胞株の開発
- 2区画式細胞培養装置の試作と機能評価
- PP104085 リコンビナント由来細胞株を用いたハイブリッド人工肝のin vivo評価 : 脳圧上昇および凝固因子減少抑制効果について
- 公共的な研究用ヒト組織バンク設立のための検討 : 国立小児病院における摘出ヒト扁桃組織バンク構築の試み. 寄せられたコメントに対する返答
- 公共的な研究用ヒト組織バンク設立のための検討 : 国立小児病院における摘出ヒト扁桃リンパ組織バンク構築の試み
- ヒト組織の利用 : 日本における現状と将来展望
- 摘出扁桃リンパ組織バンク試行からの問題提起
- PP-675 リコンビナント由来細胞株を用いたハイブリッド人工肝のin vivo評価
- 新しい免疫抑制剤と遺伝子導入による免疫制御
- 腎移植後における RS-61443 (Mycophenolate mofetil) の長期投与試験成績
- RS-61443(Mycophenolate mofetil)の腎移植後における急性拒絶反応の抑制に関する第III相臨床試験成績 - RS-61443の2, 000mg/日投与群と3,000mg/日投与群の二重盲検比較試験 -
- 腎移植後における難治性拒絶反応に以する RS-61443 (Mycophenolate mofetil) の治療効果の再検討報告
- PP-687 ラット肝移植モデルに於けるアデノウイルスベクターを用いた遺伝子導入効率の検討
- 2区画式細胞培養装置の試作と機能評価
- 肝臓を標的とする再生医療の役割 (特集 21世紀における再生医療の役割(Part2))
- 1402 ハイブリッド型人工肝のための遺伝子組換えアンモニア代謝細胞の開発
- 72-4.死体腎移植(第562回千葉医学会例会・第12回佐藤外科例会)
- 67-5.腎灌流保存装置の実用化と死体腎移植のシステムについて(第550回千葉医学会例会・第11回佐藤外科例会)
- 62-5 教室における腎移植の現況(62.研究室発表,第538回千葉医学会例会・第10回佐藤外科例会)
- 66.教室における臓器移植のあゆみ(第526回千葉医学会例会・第9回佐藤外科例会)
- 27. 同種腎移植における拒否反応の特異的診断法(第510回千葉医学会例会 第7回佐藤外科例会)
- 30. Donor選択のための白血球交差試験 : その手技の検討(第510回千葉医学会例会 第7回佐藤外科例会)
- 38. 免疫抑制剤としてのCyclophosphamideの臨床使用経験について(第510回千葉医学会例会 第7回佐藤外科例会)
- 線維素溶解現象の研究
- 16. 腎同種移植に関する基礎的研究(第414回千葉医学会例会 第14回第二外科例会)
- 23) 輸血後の白血球抗体の研究(第407回千葉医学会例会 第13回中山外科例会)
- 13.線維素溶解酵素に関する研究2. : 諸種疾患におけるプラスミンの変動について(第393回千葉医学会例会,第12回中山外科例会)
- 25.線維素溶解酵素の研究-1 : Fibrin-tube testについて(一般口演抄録,第39回千葉医学会総会,第8回千葉県医師会学術大会連合大会演説要旨)
- 8.先天性食道狭窄の1治験例(第376回千葉医学会例会,第11回中山外科例会)
- 移植と法律 : 私的35年の歴史
- PP1445 CrmA遺伝子導入によるラット同種肝移植生着延長効果
- 臓器移植医療の世界の現況 (〔2001年〕3月第5土曜特集 臓器移植の最前線) -- (社会編--臓器移植の社会資源の整備に向けて)
- 臓器移植に関する意識調査 : 臓器移植法施行後第1事例による影響